AU2021104022A4 - A Novel Polyherbal Formulation for Cessation of Pan masala - Google Patents
A Novel Polyherbal Formulation for Cessation of Pan masala Download PDFInfo
- Publication number
- AU2021104022A4 AU2021104022A4 AU2021104022A AU2021104022A AU2021104022A4 AU 2021104022 A4 AU2021104022 A4 AU 2021104022A4 AU 2021104022 A AU2021104022 A AU 2021104022A AU 2021104022 A AU2021104022 A AU 2021104022A AU 2021104022 A4 AU2021104022 A4 AU 2021104022A4
- Authority
- AU
- Australia
- Prior art keywords
- kava
- tobacco
- many
- mouth
- market
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims description 20
- 238000009472 formulation Methods 0.000 title claims description 16
- 230000000694 effects Effects 0.000 claims abstract description 7
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 14
- 229960002715 nicotine Drugs 0.000 claims description 14
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 14
- 240000005546 Piper methysticum Species 0.000 claims description 10
- 235000016787 Piper methysticum Nutrition 0.000 claims description 10
- 244000205574 Acorus calamus Species 0.000 claims description 6
- 235000011925 Passiflora alata Nutrition 0.000 claims description 6
- 235000000370 Passiflora edulis Nutrition 0.000 claims description 6
- 235000011922 Passiflora incarnata Nutrition 0.000 claims description 6
- 235000013750 Passiflora mixta Nutrition 0.000 claims description 6
- 235000013731 Passiflora van volxemii Nutrition 0.000 claims description 6
- 235000011996 Calamus deerratus Nutrition 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 4
- 240000002690 Passiflora mixta Species 0.000 claims description 3
- 230000001079 digestive effect Effects 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 3
- 241000737052 Naso hexacanthus Species 0.000 claims description 2
- 208000007117 Oral Ulcer Diseases 0.000 claims description 2
- 240000000513 Santalum album Species 0.000 claims description 2
- 235000008632 Santalum album Nutrition 0.000 claims description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 239000002417 nutraceutical Substances 0.000 claims description 2
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 235000019505 tobacco product Nutrition 0.000 claims description 2
- 241000208125 Nicotiana Species 0.000 abstract description 15
- 235000002637 Nicotiana tabacum Nutrition 0.000 abstract description 15
- 206010012335 Dependence Diseases 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract description 5
- 230000001055 chewing effect Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 abstract description 2
- 241000254173 Coleoptera Species 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 description 10
- 208000019901 Anxiety disease Diseases 0.000 description 5
- 230000036506 anxiety Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 244000080767 Areca catechu Species 0.000 description 4
- 235000006226 Areca catechu Nutrition 0.000 description 3
- 240000008440 Passiflora incarnata Species 0.000 description 3
- 108010077544 Chromatin Proteins 0.000 description 2
- 244000228367 Lewisia rediviva Species 0.000 description 2
- 235000007279 Lewisia rediviva Nutrition 0.000 description 2
- 208000003445 Mouth Neoplasms Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241001530097 Verbascum Species 0.000 description 2
- 235000010599 Verbascum thapsus Nutrition 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 235000019788 craving Nutrition 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 2
- 208000005207 oral submucous fibrosis Diseases 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 244000178289 Verbascum thapsus Species 0.000 description 1
- -1 Xanax and Valium Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 231100000024 genotoxic Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- 239000012674 herbal formulation Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017804 lesions in lung Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 238000005535 overpotential deposition Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003237 recreational drug Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940072690 valium Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 229940074158 xanax Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Addiction (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Manufacture of herbal gutka is a new concept. Chewing of beetle (popularly known as Paan)
is an age-old Indian tradition. Since last few years, many types of gutkas have been
introduced in the market and they have become very popular. Many varieties of paan or
gutka are available in the market with many ingredients including chewing tobacco.
Excessive consumption of tobacco is dangerous as it may cause cancer. Even non-tobacco
varieties are harmful in the long run with many side effects. As a matter of fact, this is a
kind of addiction. Many variants are available in the market but herbal gutka is yet to be
seen.
Description
Title of the Invention
A Novel Polyherbal Formulation for Cessation of Pan Masala
Background of the Invention
Pan masala (PM) is a mixture of areca nut with slaked lime, catechu and other flavoring agents. It is widely available and used by all the sections of the sub Asian countries. It is genotoxic as it increases sister chromatin exchange and chromatin aberrations. Among humans, it is a leading cause of oral submucous fibrosis that often progresses to oral cancer. Among experimental animals, it leads to neoplastic lesions in lung, liver and stomach. It is hepatotoxic leading to increased level of enzymes, deranged carbohydrate and lipid metabolism. It is harmful to kidneys and testes leading to increased creatinine and sperm deformities respectively. PM is a very harmful substance affecting almost all organ systems, and there is immediate need for a national policy on complete ban on the production, storage, sale and marketing of PM.6More and more people these days are walking into hospital OPDs complaining that they're increasingly unable to open their mouths. Almost all of them complain of a soreness of the mouth and constant burning in the oral cavity. Some have a nasal voice and find they can't blowout the cheeks and extend the tongue. Others complain of difficulty in swallowing. All these patients suffer from oral submucousfibrosis(SMF).
Description of the invention
As presently, there is no alternate available for gutkha,which is non toxic for healthy and also help to reduce the cravings for gutkha.There is a necessity to develop an alternate,similar in taste of gutkhas,basically fulfilling the criteria of having astringent taste,as well as having mouth freshening property too.The formulation should be easilyavailable and it should be cheaper in cost.It should act as a herbal substitute for gutkhas,pan masala and also nicotine in various forms.Another alternates such as mouth fresheners only freshen the breath,but are unable to stop the cravings for the gutkhas,which is mainly due to the presence of astringent taste containing herbal constituents.With increasing health awareness, people at large have started disliking such hazardousproducts. Thus, this is the most appropriate time to come out with an alternate productwhich is not harmful, helps reduce addiction and may prove useful. Proper understanding ofconsumer needs, attractive packaging and adequate and strategic placement are the keyfactors.Likewise, many mouth fresheners are available in the market as harmless alternatives. But herbal gukta is a new concept and would amount to concept selling. Market for gutkas is very large and scattered and it is growing very rapidly. Consumption of tobacco in any form is discouraged with restrictions like non-use at public places, no sales to children below 18 years of age and so on.
It is pertinent to mention here that the prepared formulation is not a mere admixture resulting in the aggregation of the properties of the individual ingredients, rather a synergistic mixture of herbs.
Ingredients and herbs Used in developing formulation.
Kava-Kava
For centuries, people throughout the world have used the Pacific herb kava-kava as both a recreational drug and a treatment for psychiatric disturbances. Like nicotine, kava-kava creates a temporary sense of well-being. The NIH reports that kava, which works in a manner similar to prescription benzodiazepines such as Xanax and Valium, may help to curb symptoms of anxiety, stress and agitation. Although no studies have investigated its efficacy as a nicotine substitute, it may theoretically ease "nicotine fits," or episodes of anxiety related to nicotine withdrawal. The NIH warns that kava-kava has caused liver damage, including fatal liver failure, in some individuals. Consult your health care provider before using kava-kava, especially if you have a history of liver disease.
Passionflower
Anxiety, restlessness, insomnia and agitation are among the most common and troublesome symptoms associated with nicotine withdrawal, according to the NIH. Fortunately, natural supplements made from passionflower may help to reduce these frustrating problems. The University ofMaryland Medical Center reports that passionflower may help to ease anxiety and insomnia, particularly in people with diagnosed psychiatric problems. However, these uses are based primarily based in tradition, with only limited scientific evidence to support these uses. Passionflower has a sweet fragrance and may be consumed as a tea, tincture, capsule or liquid extract.
Calamus
The calamus plant, more commonly known as bitterroot or sweet flag, contains psychoactive constituents which may be used as nicotine substitutes. When chewed, bitterroot releases a combination of chemicals which, like nicotine, exert both a stimulant and depressant effect. Herbalist Jim McDonald notes that calamus is classified as a known carcinogen by the Food and Drug Administration, but he recommends it as a helpful adjunct for relieving anxiety caused by nicotine withdrawal.
Mullein
Also known as Verbascum, mullein features in many tobacco blends as an active herbal ingredient. It acts as a great base, producing a light smoke, a subtle flavour, and a slow bum. It has been used for a very long time as a herbal remedy, and smoking it can help clear out the lungs (in smokers), encourage lymph circulation, and even sooth a sore throat.
Chewing of paan or gutka is one type of addiction with many side effects. Hence a new
concept of herbal gutka, which will not have side effects but may even help the digestive
system, is discussed in this note. The product may also result in de-addiction to some
extent. This product can be manufactured in many states like UP,Bihar, Jharkhand,Orissa
etc and this note considers Bihar as a preferred location.
Demand and Supply
After-mints are very popular throughout the country, with chewing of tobacco or non-tobacco
paan, beetle-nuts or gutka being the most popular varieties. Over a period of time, they
become addiction and it becomes extremely difficult to get rid of such habits even though
they are harmful in the long run. Likewise, many mouth fresheners are available in the market as harmless alternatives. But herbal gukta is a new concept and would amount to
concept selling. Market for gutkas is very large and scattered and it is growing very rapidly.
Consumption of tobacco in any form is discouraged with restrictions like non-use at public
places, no sales to children below 18 years of age and so on.
Need of Invention
With increasing health awareness, people at large have started disliking such hazardous
products. Thus, this is the most appropriate time to come out with an alternate product
which is not harmful, helps reduce addiction and may prove useful. Proper understanding of
consumer needs, attractive packaging and adequate and strategic placement are the key factors.
The process of manufacture is simple. All the ingredients are cleaned and passed through
sieves to remove impurities. They are then ground individually in roller grinder. Then all of
them are blended in a blender to obtain a homogenous mix. Finally, the desired quantity is
packed in printed pouches on form, fill and seal machine.
Raw Materials (Constituents)
Kava-Kava in between 10-15 %
Saufin between 15-20 %
Calamus 10-15 %
Passionflower 10-15 %
Kava-Kava 5-15 %
Sandalwood Powder 4-10 %
Mulethiin between 3-10 %
Sunthiin between 5-10 %
Mullien in between 5-10 %
Kala Namakin between 3-5 %
The nicotine free polyherbal masticatory formulation of the present invention is safe to be used orally as the components used in the formulation are of herbal origin and do not produce any adverse side effect on the mouth as well as other organs of the body.
The formulation is eco-friendly and economically viable. No harmful components like tobacco are used in the formulation which can cause oral cancer.
Besides being an alternate of health affecting Gutkha, it is a source of many minerals, vitamins, carbohydrates and possesses anti-oxidant property, while improving digestion and boosting immunity.
Novelty
Many herbal formulations are available in the prior art for de-addiction of tobacco but none of them are safe and effective enough to overcome the withdrawal symptoms of nicotine containing tobacco products. In addition, none of the formulations available for deaddiction show any nutraceutical effect.
Summary
The main objective of the present invention is to provide a synergistic polyherbal tobacco/ nicotine free masticatory formulation, which obviates the drawbacks of all present forms of tobacco based formulations and exhibits positive effects on the human health along with tobacco de-addiction property.Our formulation Does not cause bad smell from mouth, and Helps in caring mouth ulcers and cuts caused due to eating pan masala and gutkha.After eating this, the person feels refreshing and does not feel the urge to eat/take things contain nicotine, pan masala and gutkha. It Can be eaten as a mouth freshener after meals as digestive supplement. No need for spitting.It will keep away from you Cancer, COPD, Chronic Bronchitis, Emphysema, and Ulcer Etc.We all know pan masala that causes a number of health problems due to its tobacco content.Our formulation will give you the same feeling and taste of pan masala but it is free from tobacco and areca-nut (supari).
Claims (5)
1. 1.We claim to form a formulations overcome the withdrawal symptoms of nicotine containing tobacco products.
2. We also claim that in this invention none of the formulations available for deaddiction show any nutraceutical effect.
3. We claim, it Does not cause bad smell from mouth, and Helps in caring mouth ulcers and cuts caused due to eating pan masala
4. We Claim it It Can be eaten as a mouth freshener after meals as digestive supplement
5. WE claims the constituents
Kava-Kava in between 10-15 %
Saufin between 15-20 %
Calamus 10-15 %
Passionflower 10-15 %
Kava-Kava 5-15 %
Sandalwood Powder 4-10 %
Mulethiin between 3-10 %
Sunthiin between 5-10 %
Mullien in between 5-10 %
Kala Namakin between 3-5 %
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021104022A AU2021104022A4 (en) | 2021-07-09 | 2021-07-09 | A Novel Polyherbal Formulation for Cessation of Pan masala |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021104022A AU2021104022A4 (en) | 2021-07-09 | 2021-07-09 | A Novel Polyherbal Formulation for Cessation of Pan masala |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021104022A4 true AU2021104022A4 (en) | 2022-04-21 |
Family
ID=81210296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021104022A Ceased AU2021104022A4 (en) | 2021-07-09 | 2021-07-09 | A Novel Polyherbal Formulation for Cessation of Pan masala |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021104022A4 (en) |
-
2021
- 2021-07-09 AU AU2021104022A patent/AU2021104022A4/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Winstock et al. | A dependency syndrome related to areca nut use: some medical and psychological aspects among areca nut users in the Gujarat community in the UK | |
Williams et al. | Sociocultural aspects of areca nut use | |
Sankhla et al. | Genotoxic and carcinogenic effect of gutkha: a fast-growing smokeless tobacco | |
JP2003183174A (en) | Composition for insomnia | |
AU2021104022A4 (en) | A Novel Polyherbal Formulation for Cessation of Pan masala | |
Jalilovna et al. | The Negative Impact of the Nasvai on the Body of a Teenager | |
WO2022002996A1 (en) | Oral freshness composition | |
White et al. | The herbal drugstore: the best natural alternatives to over-the-counter and prescription medicines! | |
Vikneshan et al. | Smokeless tobacco and its adverse effects on oral cavity-an overview | |
RU2769307C1 (en) | Interconnected sachets with active ingredient | |
US5130132A (en) | Composition and method for treating nicotine dependency | |
Goolsby | Smokeless tobacco: The health consequences of snuff and chewing tobacco | |
US9198943B2 (en) | Silene capensis for inhibiting cravings | |
Doege | Health effects of smokeless tobacco | |
Bissessur et al. | Areca nut and tobacco chewing habits in Durban, KwaZulu Natal: scientific | |
US20080017205A1 (en) | Method and Device for Releasing Flavor and Odor Substances | |
Cox et al. | Oral and systemic health effects of compulsive areca nut use | |
British Medical Association | More Secret Remedies: What They Cost & what They Contain: Secret Remedies--second Series | |
JP2015166328A (en) | Chewable tablet | |
RU2134585C1 (en) | Biologically active food additive "korrida" for losing the habit of smoking | |
Bethard | Lotions, Potions, and Deadly Elixirs: Frontier Medicine in America | |
Tilling | Smoking and Vaping | |
Weil | Letters from Andrew Weil: The green and the white | |
WO2021078999A1 (en) | Chewing gum or lozenge composition comprising cbd | |
Moghaddam et al. | SciMedicine Journal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) | ||
MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |